Cargando…

High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo

We have observed that of the 10 AAV serotypes, AAV6 is the most efficient in transducing primary human hematopoietic stem cells (HSCs), and that the transduction efficiency can be further increased by specifically mutating single surface-exposed tyrosine (Y) residues on AAV6 capsids. In the present...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Liujiang, Li, Xiaomiao, Jayandharan, Giridhara R., Wang, Yuan, Aslanidi, George V., Ling, Chen, Zhong, Li, Gao, Guangping, Yoder, Mervin C., Ling, Changquan, Tan, Mengqun, Srivastava, Arun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597592/
https://www.ncbi.nlm.nih.gov/pubmed/23516552
http://dx.doi.org/10.1371/journal.pone.0058757
_version_ 1782262654948081664
author Song, Liujiang
Li, Xiaomiao
Jayandharan, Giridhara R.
Wang, Yuan
Aslanidi, George V.
Ling, Chen
Zhong, Li
Gao, Guangping
Yoder, Mervin C.
Ling, Changquan
Tan, Mengqun
Srivastava, Arun
author_facet Song, Liujiang
Li, Xiaomiao
Jayandharan, Giridhara R.
Wang, Yuan
Aslanidi, George V.
Ling, Chen
Zhong, Li
Gao, Guangping
Yoder, Mervin C.
Ling, Changquan
Tan, Mengqun
Srivastava, Arun
author_sort Song, Liujiang
collection PubMed
description We have observed that of the 10 AAV serotypes, AAV6 is the most efficient in transducing primary human hematopoietic stem cells (HSCs), and that the transduction efficiency can be further increased by specifically mutating single surface-exposed tyrosine (Y) residues on AAV6 capsids. In the present studies, we combined the two mutations to generate a tyrosine double-mutant (Y705+731F) AAV6 vector, with which >70% of CD34(+) cells could be transduced. With the long-term objective of developing recombinant AAV vectors for the potential gene therapy of human hemoglobinopathies, we generated the wild-type (WT) and tyrosine-mutant AAV6 vectors containing the following erythroid cell-specific promoters: β-globin promoter (βp) with the upstream hyper-sensitive site 2 (HS2) enhancer from the β-globin locus control region (HS2-βbp), and the human parvovirus B19 promoter at map unit 6 (B19p6). Transgene expression from the B19p6 was significantly higher than that from the HS2-βp, and increased up to 30-fold and up to 20-fold, respectively, following erythropoietin (Epo)-induced differentiation of CD34(+) cells in vitro. Transgene expression from the B19p6 or the HS2-βp was also evaluated in an immuno-deficient xenograft mouse model in vivo. Whereas low levels of expression were detected from the B19p6 in the WT AAV6 capsid, and that from the HS2-βp in the Y705+731F AAV6 capsid, transgene expression from the B19p6 promoter in the Y705+731F AAV6 capsid was significantly higher than that from the HS2-βp, and was detectable up to 12 weeks post-transplantation in primary recipients, and up to 6 additional weeks in secondary transplanted animals. These data demonstrate the feasibility of the use of the novel Y705+731F AAV6-B19p6 vectors for high-efficiency transduction of HSCs as well as expression of the b-globin gene in erythroid progenitor cells for the potential gene therapy of human hemoglobinopathies such as β-thalassemia and sickle cell disease.
format Online
Article
Text
id pubmed-3597592
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-35975922013-03-20 High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo Song, Liujiang Li, Xiaomiao Jayandharan, Giridhara R. Wang, Yuan Aslanidi, George V. Ling, Chen Zhong, Li Gao, Guangping Yoder, Mervin C. Ling, Changquan Tan, Mengqun Srivastava, Arun PLoS One Research Article We have observed that of the 10 AAV serotypes, AAV6 is the most efficient in transducing primary human hematopoietic stem cells (HSCs), and that the transduction efficiency can be further increased by specifically mutating single surface-exposed tyrosine (Y) residues on AAV6 capsids. In the present studies, we combined the two mutations to generate a tyrosine double-mutant (Y705+731F) AAV6 vector, with which >70% of CD34(+) cells could be transduced. With the long-term objective of developing recombinant AAV vectors for the potential gene therapy of human hemoglobinopathies, we generated the wild-type (WT) and tyrosine-mutant AAV6 vectors containing the following erythroid cell-specific promoters: β-globin promoter (βp) with the upstream hyper-sensitive site 2 (HS2) enhancer from the β-globin locus control region (HS2-βbp), and the human parvovirus B19 promoter at map unit 6 (B19p6). Transgene expression from the B19p6 was significantly higher than that from the HS2-βp, and increased up to 30-fold and up to 20-fold, respectively, following erythropoietin (Epo)-induced differentiation of CD34(+) cells in vitro. Transgene expression from the B19p6 or the HS2-βp was also evaluated in an immuno-deficient xenograft mouse model in vivo. Whereas low levels of expression were detected from the B19p6 in the WT AAV6 capsid, and that from the HS2-βp in the Y705+731F AAV6 capsid, transgene expression from the B19p6 promoter in the Y705+731F AAV6 capsid was significantly higher than that from the HS2-βp, and was detectable up to 12 weeks post-transplantation in primary recipients, and up to 6 additional weeks in secondary transplanted animals. These data demonstrate the feasibility of the use of the novel Y705+731F AAV6-B19p6 vectors for high-efficiency transduction of HSCs as well as expression of the b-globin gene in erythroid progenitor cells for the potential gene therapy of human hemoglobinopathies such as β-thalassemia and sickle cell disease. Public Library of Science 2013-03-14 /pmc/articles/PMC3597592/ /pubmed/23516552 http://dx.doi.org/10.1371/journal.pone.0058757 Text en © 2013 Song et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Song, Liujiang
Li, Xiaomiao
Jayandharan, Giridhara R.
Wang, Yuan
Aslanidi, George V.
Ling, Chen
Zhong, Li
Gao, Guangping
Yoder, Mervin C.
Ling, Changquan
Tan, Mengqun
Srivastava, Arun
High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo
title High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo
title_full High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo
title_fullStr High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo
title_full_unstemmed High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo
title_short High-Efficiency Transduction of Primary Human Hematopoietic Stem Cells and Erythroid Lineage-Restricted Expression by Optimized AAV6 Serotype Vectors In Vitro and in a Murine Xenograft Model In Vivo
title_sort high-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized aav6 serotype vectors in vitro and in a murine xenograft model in vivo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3597592/
https://www.ncbi.nlm.nih.gov/pubmed/23516552
http://dx.doi.org/10.1371/journal.pone.0058757
work_keys_str_mv AT songliujiang highefficiencytransductionofprimaryhumanhematopoieticstemcellsanderythroidlineagerestrictedexpressionbyoptimizedaav6serotypevectorsinvitroandinamurinexenograftmodelinvivo
AT lixiaomiao highefficiencytransductionofprimaryhumanhematopoieticstemcellsanderythroidlineagerestrictedexpressionbyoptimizedaav6serotypevectorsinvitroandinamurinexenograftmodelinvivo
AT jayandharangiridharar highefficiencytransductionofprimaryhumanhematopoieticstemcellsanderythroidlineagerestrictedexpressionbyoptimizedaav6serotypevectorsinvitroandinamurinexenograftmodelinvivo
AT wangyuan highefficiencytransductionofprimaryhumanhematopoieticstemcellsanderythroidlineagerestrictedexpressionbyoptimizedaav6serotypevectorsinvitroandinamurinexenograftmodelinvivo
AT aslanidigeorgev highefficiencytransductionofprimaryhumanhematopoieticstemcellsanderythroidlineagerestrictedexpressionbyoptimizedaav6serotypevectorsinvitroandinamurinexenograftmodelinvivo
AT lingchen highefficiencytransductionofprimaryhumanhematopoieticstemcellsanderythroidlineagerestrictedexpressionbyoptimizedaav6serotypevectorsinvitroandinamurinexenograftmodelinvivo
AT zhongli highefficiencytransductionofprimaryhumanhematopoieticstemcellsanderythroidlineagerestrictedexpressionbyoptimizedaav6serotypevectorsinvitroandinamurinexenograftmodelinvivo
AT gaoguangping highefficiencytransductionofprimaryhumanhematopoieticstemcellsanderythroidlineagerestrictedexpressionbyoptimizedaav6serotypevectorsinvitroandinamurinexenograftmodelinvivo
AT yodermervinc highefficiencytransductionofprimaryhumanhematopoieticstemcellsanderythroidlineagerestrictedexpressionbyoptimizedaav6serotypevectorsinvitroandinamurinexenograftmodelinvivo
AT lingchangquan highefficiencytransductionofprimaryhumanhematopoieticstemcellsanderythroidlineagerestrictedexpressionbyoptimizedaav6serotypevectorsinvitroandinamurinexenograftmodelinvivo
AT tanmengqun highefficiencytransductionofprimaryhumanhematopoieticstemcellsanderythroidlineagerestrictedexpressionbyoptimizedaav6serotypevectorsinvitroandinamurinexenograftmodelinvivo
AT srivastavaarun highefficiencytransductionofprimaryhumanhematopoieticstemcellsanderythroidlineagerestrictedexpressionbyoptimizedaav6serotypevectorsinvitroandinamurinexenograftmodelinvivo